JPMAM teams up with UBS Global Wealth Management to launch machine learning fund

Combines machine learning and active equity

J.P. Morgan Asset Management (JPMAM) has launched JP Morgan Funds Genetic Therapies, an actively managed fund, in partnership with UBS Global Wealth Management.

The fund will combine "machine learning and active equity insights" and leverages UBS research from its longer term investments framework. Genetic therapies are at an "inflection point", currently moving from "clinic to commercial reality", JPMAM said. The Genetic Therapies fund aims to provide investors with the chance to "gain diversified exposure" to this "new and exciting" theme, while helping to hedge the risk of "disruption" to healthcare portfolios. Why healthcare sector is ripe for disruption The fund will be co-managed by Yazann Romahi, Berkan Sesen and Ajiaz Hussein, w...